Nearly two-thirds have not received standardized and reasonable treatment, and at least 9 million epilepsy patients in China have been diagnosed and treated | epilepsy | China

Release time:Apr 13, 2024 23:04 PM

June 28th this year is the 17th International Epilepsy Care Day, and the China Anti Epilepsy Association has designated the promotional theme of this year's Day as "Standardized Diagnosis and Treatment of Epilepsy: From Within Hospital to Outside Hospital". This morning, the "International Epilepsy Care Day Main Venue Event" was jointly organized by the China Anti Epilepsy Association and the Shanghai Anti Epilepsy Association, and co organized by the Pediatric Hospital affiliated with Fudan University, Huashan Hospital affiliated with Fudan University, and Zhongshan Hospital affiliated with Fudan University. It was reported that there are at least 9 million epilepsy patients in China, and nearly two-thirds of them have not received standardized and reasonable treatment. Diagnosis and treatment from inside to outside the hospital has become the key to effectively improve epilepsy diagnosis and treatment capabilities and improve the quality of life of patients.

Epilepsy is the most common chronic neurological disease, with a long course that involves the entire life cycle and can occur from newborns to the elderly; The symptoms of epilepsy are diverse and the causes are complex. Common causes include hereditary epilepsy, developmental abnormalities of the brain, stroke, traumatic brain injury, encephalitis, brain tumors, autism, senile dementia, Parkinson's disease, etc. Epilepsy is often a critical and life-threatening condition, with seizure related diseases accounting for 1/4 of emergency visits; The treatment of epilepsy is relatively difficult and requires the use of anti epileptic drugs, surgery, neuromodulation, ketogenic diet, immunotherapy, or targeted drug therapy. One third of the cases are intractable epilepsy, accompanied by various neurological and psychiatric comorbidities, requiring multidisciplinary joint diagnosis, treatment, and management.

The World Health Organization has listed epilepsy as a key neurological and psychiatric disease for prevention and treatment. The World Health Organization proposed in the "2022-2031 Cross sectoral Global Action Plan for Epilepsy and Other Neurological Diseases" that member states should strengthen the prevention, treatment, and care of epilepsy as much as possible, increase access to care and treatment for patients with neurological diseases, including epilepsy, prevent new cases, and promote brain health and development throughout life. This strategy provides important support for promoting and strengthening social services and innovative models related to epilepsy at a macro level.

With the transformation of modern medical models and the innovation of chronic disease management models, the concept of standardized diagnosis and treatment for epilepsy has also extended from traditional in hospital diagnosis and treatment to the whole disease process standardization around "pre diagnosis, during diagnosis, and after diagnosis". Providing standardized diagnosis and treatment for epilepsy patients throughout the entire disease process both inside and outside the hospital has become the latest management goal. For example, how to provide correct first aid for epileptic seizures? What kind of medical institution and epilepsy center should I choose? How to conduct standardized and convenient remote follow-up, medication prescription, and follow-up? How to achieve efficient and orderly consultation and referral? The long-term management of epilepsy and chronic diseases in the community is also an important and standardized aspect that must be considered. This requires both hospitals and doctors, as well as the joint efforts of all sectors of society, in order to enable epilepsy patients to receive maximum assistance, control disease seizures, improve quality of life, and return to the normal track of life.

The standardized diagnosis and treatment of epilepsy patients has always been a basic requirement for disease diagnosis and treatment, and it is also a key focus of attention and scientific education for the whole society. Improving patient compliance, promoting the sinking of high-quality medical resources, promoting accessibility of medical services, reducing disease burden, and supporting the Healthy China strategy, the China Anti Epilepsy Association, as an industry organization in the field of epilepsy, has been striving, calling for, and taking action.


Nearly two-thirds have not received standardized and reasonable treatment, and at least 9 million epilepsy patients in China have been diagnosed and treated | epilepsy | China

After 6 years of effort, China has established a standardized three-level epilepsy center network system and further strengthened the standardized construction of epilepsy centers. The China Anti Epilepsy Association has promoted the establishment and evaluation of 294 epilepsy centers nationwide, covering 31 provinces, municipalities, and autonomous regions. The standardized epilepsy center, composed of a multidisciplinary team specializing in epilepsy diagnosis and treatment, including neurology, pediatrics, neurosurgery, neurophysiology, neuroimaging, neuropharmacology, neuronursing, and neuropathology, will provide important guarantees for the standardized construction and high-quality medical treatment of epilepsy in China. It has gradually formed a Chinese epilepsy diagnosis and treatment model and plan, and is making unremitting efforts to promote the rapid development of epilepsy in China.

On the occasion of the 17th International Epilepsy Care Day, the China Anti Epilepsy Association specially promotes the concept of "standardized diagnosis and treatment of epilepsy, both in and out of hospital" to the public, patients, and their families. It encourages patients and their families to actively participate in disease management, and looks forward to all relevant parties in society taking active action to make their own efforts to standardize the diagnosis and treatment of epilepsy.

Mr. Lang Lang, the Children's Health Ambassador and internationally renowned pianist at the Affiliated Pediatric Hospital of Fudan University, was invited to participate in the event online, encouraging patients to build confidence, overcome diseases, and return to normal life. At the event, attending experts connected with epilepsy diagnosis and treatment aid bases in Ningxia and Yunnan to deeply understand and explore new developments in epilepsy treatment and remote assistance in remote areas of China.

The Epilepsy Center of Huashan Hospital affiliated with Fudan University, in collaboration with Shanghai Academy of Drama, has specially arranged a science popularization single act play "99th Square Fate" for epilepsy patients. It is scheduled to be publicly performed at this event, promoting the elimination of epilepsy discrimination, popularizing knowledge on emergency treatment for epilepsy, and the actors' wonderful performances and the love behind the story deeply moved the audience and the applause echoed for a long time.

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended